What is Zura Bio Limited Class A Ordinary Shares?
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 119.44M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.